2-(3,4-dihydroxy-1-oxidopyridin-1-ium-2-yl)-3,4-dihydroxypyridin-1-ium-1-olate, 10mg

2-Propylcyclohexan-1-ol, 95%, 25g

3-(6-Chloro-1H-benzoimidazol-2-yl)-propionic acid, 95.0%, 2.5g

2,5,8,11,14-Pentaoxaheptadecan-17-oic acid, 98%, 5g

(S)-2-Amino-1,1-diphenylpropan-1-ol, 95.0%, 10g

(1R,4S,4aR,9aS)-rel-4a-Methyl-1,4,4a,9a-tetrahydro-1,4-methanoanthracene-9,10-dione, 95.0%, 5g

(R)-3-Amino-3-(2-nitrophenyl)propanoic acid, 98%, 100mg

1,3,3A,4,6,6A-HEXAHYDROCYCLOPENTA[C]THIOPHEN-5-ONE, 95.0%, 10g

(2E)-3-(2H-1,3-benzodioxol-5-yl)-1-(4-nitrophenyl)prop-2-en-1-one, 95.0%, 10g

2-Chloro-3-ethyl-3H-benzo[d]oxazol-1-ium tetrafluoroborate, 97%, 5g

Incubadora Heratherm Protocol series Protocolo general con convección natural, 194 l, IGS180, 1 pieza

H-D-Ser-OMe.HCl>98.0%(T)25g

4-Bromo-2-(difluoromethoxy)benzaldehyde, 98%, 100mg